By Karen E. Roman Apollomics, Inc. (Nasdaq: APLM), a biopharmaceutical company that develops medicines for difficult-to-treat cancers, said it appointed Matthew Plunkett, Ph.D., as Chief Financial Officer. Dr. Plunkett has over 25 years of strategic and financial experience within the...

By Exec Edge Editorial Staff RBC Capital analyst Shagun Singh maintained Zynex, Inc. (Nasdaq:ZYXI) with an outperform rating and raised its price target from $13 to $15. Meanwhile, HC Wainwright & Co. analyst Yi Chen maintained a buy rating and...

By Daniella Parra FIGS, Inc. (NYSE: FIGS) said fourth quarter net revenue was $144.9 million and a reclassification negatively impacted net revenues by $4.7 million. Gross margin was 67.5%, a decrease of 70 basis points and operating expenses were $83.6...

By Daniella Parra Vivani Medical, Inc. (Nasdaq: VANI) reported promising preclinical data on NPM-115, a miniature exenatide implant for chronic weight management. The company focuses on GLP-1 implants for obesity treatment due to their potential to improve patient outcomes, which...

By Karen E. Roman Portillo’s Inc. (NASDAQ: PTLO), the casual restaurant known for its Chicago-style favorites menu, reported a 24.5% increase in total revenue for the last quarter of 2023 and a rise of 4.4% on same-restaurant sales. Operating income...

Exec Edge interviewed WHY Brands Inc. Founder and CEO Steven Dunn, Chief Brand Officer & Creative Officer Diana Barnes WHY has been transforming itself into a house of brands including Munchkin, Curio Dunn and Ms. Barnes co-founded lifestyle products company...

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) announced Padraig McDonnell, president of the Agilent CrossLab Group (ACG), as CEO-elect and chief operating officer, succeeding Mike McMullen, the current President and CEO, who will retire. Agilent said McDonnell has held...

  By Karen E. Roman Planet Fitness, Inc. (NYSE: PLNT) reported total revenue grew 1.4% on the fourth quarter to $285.1 million and system-wide same store sales rose 7.7%. Adjusted EBITDA grew 7.8% to $114.3 million from $106.1 million the...

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it demonstrated that VXX-401 lowers LDL cholesterol, supporting its potential for treating hypercholesterolemia. The VXX-401, a synthetic peptide vaccine, aims to provide a safe and effective solution against heart disease by targeting...

By Daniella Parra Brii Biosciences and VBI Vaccines (NASDAQ: VBIV) said they will expand and control of BRII-179 supplies, a late-stage asset for HBV functional cure. Initially, a $2.5 million promissory note will be issued, eliminating royalty and milestone payments...